Learning Hub Central
Lung
2025 WCS | Novel Treatments in NSCLC: Antibody Drug Conjugates (ADC), Bi-Specifics and Vaccines
Lung
Non-CME Credit Course
2025 WCS | First-Line Targeted Therapies in NSCLC: What’s New?
Lung
Non-CME Credit Course
2025 WCS | Immunotherapy for NSCLC: First Line and What Is After Progression?
Lung
Non-CME Credit Course
2025 WCS | Neoadjuvant-Adjuvant-Perioperative Immunotherapy in NSCLC
Lung
Non-CME Credit Course
2025 WCS | Limited- and Extensive-Disease Small Cell Lung Cancer (SCLC): New Standard of Care and Novel Advances
Lung
Non-CME Credit Course
2022 Best of WCLC | Small Cell Lung Cancer
Lung
Non-CME Credit Course
New Therapeutic Directions in Lung Cancer
Lung
Non-CME Credit Course
Mesothelioma and Thymoma – Limited and Advanced Stage
Lung
Non-CME Credit Course
Other Immunotherapy Targets & Agents- Advanced NSCLC
Lung
Non-CME Credit Course
PD-1/PD-L1 Directed Immunotherapy for Advanced NSCLC
Lung
Non-CME Credit Course
2022 Best of WCLC | EGFR Mutated Lung Cancer - Advanced Stage
Lung
Non-CME Credit Course
ALK, ROS1, and BRAF Positive Lung Cancer
Lung
Non-CME Credit Course
2022 Best of WCLC | Tumor Biology, Pathology, Novel Diagnostics
Lung
Non-CME Credit Course
2023 Best of WCLC San Francisco | Palliative Care Approaches in Lung Cancer
Lung
Non-CME Credit Course
Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy
Lung
Non-CME Credit Course
Stage III NSCLC – Surgical/Combined Modality
Lung
Non-CME Credit Course
Locally Advanced NSCLC- Radiation Therapy
Lung
Non-CME Credit Course
2022 Best of WCLC | Radiation in Early-Stage NSCLC
Lung
Non-CME Credit Course
2022 Best of WCLC | Adjuvant/Neo-adjuvant Systemic Therapy
Lung
Non-CME Credit Course
Surgery for Early-Stage NSCLC
Lung
Non-CME Credit Course
Pulmonary – From Diagnostics to Therapeutics
Lung
Non-CME Credit Course
Lung Cancer Screening / Tobacco Control
Lung
Non-CME Credit Course
2025 MCM | Updates on SCLC and Mesothelioma
Lung
Non-CME Credit Course
2025 MCM | ADC in NSCLC: Too Much Hope?
Lung
Non-CME Credit Course
2025 MCM | Updated Management on Advanced NSCLC Driver Mutant Tumors
Lung
Non-CME Credit Course
2025 MCM | Stage III Unresectable NSCLC: Any Progress Beyond PACIFIC?
Lung
Non-CME Credit Course
2025 MCM | Utilization of Immunotherapy in the Perioperative Setting
Lung
Non-CME Credit Course
2024 MLS Irvine | Target Therapy Updates
Lung
Non-CME Credit Course
2024 MLS Irvine | Immunotherapy Updates in Lung Cancer
Lung
Non-CME Credit Course
2024 NOSCM | Small Cell Lung Cancer: Targeting This Difficult Target
Lung
Non-CME Credit Course
2024 NOSCM | Non Driver NSCLC: The Immunotherapy Strategy
Lung
Non-CME Credit Course
2024 NOSCM | Other Driver Mutations: ROS-1, BRAF, MET and RET
Lung
Non-CME Credit Course
2024 NOSCM | K-RAS Therapies in NSCLC
Lung
Non-CME Credit Course
2024 NOSCM | ALK: First Line and Mechanism Of Resistance
Lung
Non-CME Credit Course
2024 NOSCM | EGFR Exon 20 Insertions: Novel Agents
Lung
Non-CME Credit Course
2024 NOSCM | What Is Next After Osimertinib Progression?
Lung
Non-CME Credit Course
2024 NOSCM | Lung Cancer With EGFR Exon 19 and L858R Mutations: The Optimal Front Line Therapy
Lung
Non-CME Credit Course
2024 NOSCM | Optimal Surgical Approach in Early Stages NSCLC
Lung
Non-CME Credit Course
2024 NOSCM | Screening in Lung Cancer: Challenges and Obstacles
Lung
Non-CME Credit Course
2024 NOSCM | Challenges in Lung Cancer Pathology: Biomarkers
Lung
Non-CME Credit Course
ctDNA in Lung Cancer: Current State and Future Perspectives
Lung
Non-CME Credit Course
2022 Best of WCLC | Other Oncogene-Driven Cancers
Lung
Non-CME Credit Course
PD-1 Inhibitor Update
Lung
Non-CME Credit Course
2024 NOSCM | Adjuvant Therapies in NSCLC
Lung
Non-CME Credit Course
2024 MLS Nashville | Target Therapy Updates in Lung Cancer 2024
Lung
Non-CME Credit Course
Immunotherapy Updates in Lung Cancer 2024
Lung
Non-CME Credit Course
2024 MCM | Bi-Specific Inhibitor & ADC in Lung Cancer
Lung
Non-CME Credit Course
2024 MCM | Immunotherapy in NSCLC: First Line for Advanced Disease
Lung
Non-CME Credit Course
2024 MCM | Front Line Targeted Therapy in NSCLC: Tyrosine Kinase Inhibitors
Lung
Non-CME Credit Course
2024 MCM | Controversies in Lung Cancer: Neoadjuvant vs Adjuvant IO in Early Stage NSCLC
Lung
Non-CME Credit Course
2024 MLS Cleveland | Targeted Therapy Updates in NSCLC
Lung
Non-CME Credit Course
2024 MLS New Orleans | Master Lecture on Antibody Drug Conjugates & Bispecific Antibodies in NSCLC
Lung
Non-CME Credit Course
2024 MLS New Orleans | Master Lecture on Immunotherapy in NSCLC: Metastatic Setting and What is After First Line IO Failure
Lung
Non-CME Credit Course
2024 MLS New Orleans | Master Lecture on Targeting NSCLC Driver Pathways
Lung
Non-CME Credit Course
2024 MLS New Orleans | Master Lecture on Small Cell: The Updates
Lung
Non-CME Credit Course
Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 2)
Lung
Non-CME Credit Course
Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 1)
Lung
Non-CME Credit Course
2024 WCS | Efforts to Overcome Resistance to First Line Immunotherapy
Lung
Non-CME Credit Course
2024 WCS | Immunotherapy in Metastatic NSCLC: How to Choose Initial Therapy and What’s New?
Lung
Non-CME Credit Course
2024 WCS | Antibody Drug Conjugates in NSCLC
Lung
Non-CME Credit Course
2024 WCS | KRAS and EGFR Exon 20 Insertion
Lung
Non-CME Credit Course
2024 WCS | MET, RAF and NTRK
Lung
Non-CME Credit Course
2024 WCS | ALK, ROS-1 and RET
Lung
Non-CME Credit Course
EGFR and Resistant Mechanisms
Lung
Non-CME Credit Course
2024 PRIMO | Neoadjuvant and Adjuvant Immunotherapy
Lung
Non-CME Credit Course
2024 PRIMO | What’s New in EGFR, ALK, RET and c-MET
Lung
Non-CME Credit Course
2024 PRIMO | New Agents after Immunotherapy Resistance
Lung
Non-CME Credit Course
2023 UCT | New Developments in EGFR and K-RAS Therapies in NSCLC
Lung
Non-CME Credit Course
2023 UCT | Updates on Targeting ALK, ROS1 ,and RET in NSCLC
Lung
Non-CME Credit Course
2022 UCT | Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC
Lung
Non-CME Credit Course
2023 UCT | The Era of Antibody Drug Conjugates in NSCLC Targeting Her-2, CEACAM5, TROP-2, and MET
Lung
Non-CME Credit Course
2024 SPECTRUM | Robotic assisted Lung ablations
Lung
Non-CME Credit Course
2024 SPECTRUM | PEF in Lung Cancer
Lung
Non-CME Credit Course
2024 SPECTRUM | Approach to lung cancer in the UK
Lung
Non-CME Credit Course
2024 SPECTRUM | Optimizing radiation in primary lung malignancies
Lung
Non-CME Credit Course
2024 SPECTRUM | Advances in chemotherapy in Lung cancer
Lung
Non-CME Credit Course
2023 MLS Denver | Later lines of Treatment for NSCLC
Lung
Non-CME Credit Course
2023 MLS Denver | Immunotherapy Toxicities and Lung Biomarkers
Lung
Non-CME Credit Course
2022 MLS Denver | Lung Immunotherapy
Lung
Non-CME Credit Course
2022 MLS Denver | Targeted Therapies in Lung Cancer
Lung
Non-CME Credit Course
2022 MLS Denver | Early-Stage/Locally Advanced Lung Cancer
Lung
Non-CME Credit Course
Updates in Treatment of Early Stage and Locally Advanced NSCLC
Lung
Non-CME Credit Course
2023 CCC | Advances in Small Cell Lung Cancer and Mesothelioma/Thymic Malignancies
Lung
Non-CME Credit Course
Updates in Targeted Therapy for NSCLC
Lung
Non-CME Credit Course
Updates in Immunotherapy for Lung Cancer
Lung
Non-CME Credit Course
2022 NOSCM | Immunotherapy in Advanced/Metastatic NSCLC and What After IO Failures?
Lung
Non-CME Credit Course
2022 MLS New Orleans | Targeted Therapy in Lung Cancer
Lung
Non-CME Credit Course
Immunotherapy in Lung Cancer
Lung
Non-CME Credit Course
2023 MLS Arlington | Management of EGFR/ALK resistance
Lung
Non-CME Credit Course
2022 UCT | Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC
Lung
Non-CME Credit Course
2022 UCT | Advances in Targeted Therapy in Lung Cancer
Lung
Non-CME Credit Course
2022 MLS New Orleans | Mechanism of Resistance to EGFR-ALK & Other Relevant Pathways
Lung
Non-CME Credit Course
2022 MLS New Orleans | Immunotherapy in Lung Cancer: NEOADJ, ADJ and LA Disease
Lung
Non-CME Credit Course
Advances in Small Cell Lung Cancer and Mesothelioma
Lung
Non-CME Credit Course
2022 NOSCM | RET, MET & NTRK Mutations in NSCLC
Lung
Non-CME Credit Course
2022 NOSCM | ALK, ROS1 & BRAF Mutations in NSCLC
Lung
Non-CME Credit Course
2022 NOSCM | EGFR, K-RAS and ERBB2 Mutations in NSCLC
Lung
Non-CME Credit Course
2022 NOSCM | Novel Treatment Strategies for Stage III NSCLC Beyond PACIFIC
Lung
Non-CME Credit Course
2021 NOSCM | Adjuvant and Neoadjuvant Novel Concepts and Strategies in NSCLC
Lung
Non-CME Credit Course
2021 NOSCM | Small Cell Lung Cancer: After Immunochemotherapy, What’s Next?
Lung
Non-CME Credit Course
2022 NOSCM | Novel Platforms for Lung Cancer Screening Using Liquid Biopsy
Lung
Non-CME Credit Course
2022 MLS Nashville | Immunotherapy in Advanced/ Metastatic NSCLC
Lung
Non-CME Credit Course
2022 MLS Nashville | Lung Adenocarcinoma Updates
Lung
Non-CME Credit Course
2022 MCM | Clinical Utility and Future indications of Liquid Biopsies in Lung Cancer
Lung
Non-CME Credit Course
Stage III NSCLC: Beyond the PACIFIC/ Novel Approaches
Lung
Non-CME Credit Course
2022 MCM | How to Choose Front Line Therapy for Metastatic Non-Driver Mutation NSCLC
Lung
Non-CME Credit Course
2022 MCM | Lung Cancer Neoadjuvant and Adjuvant Immunotherapy
Lung
Non-CME Credit Course
2022 MCM | Uncommon Mutations/Fusions: EGFRex20ins, RET, MET, Her2, NRG1
Lung
Non-CME Credit Course
2022 MCM | Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations
Lung
Non-CME Credit Course
2022 MCM | Toxicity Management of Novel Agents in Lung Cancer (RET, MET & KRAS G-12)
Lung
Non-CME Credit Course
2021 NOSCM | RET, MET & B-RAF mutations in NSCLC
Lung
Non-CME Credit Course
2021 NOSCM | ERBB2 and NGR1 Pathways in NSCLC
Lung
Non-CME Credit Course
2021 NOSCM | ALK, ROS1 & NTRK Mutations in NSCLC
Lung
Non-CME Credit Course
2021 NOSCM | EGFR and K-RAS Mutations in NSCLC
Lung
Non-CME Credit Course
2021 NOSCM | Lung Cancer Clinical Scenarios: How Liquid Biopsy Technology Is Delivering Personalized Therapy in NSCLC
Lung
Non-CME Credit Course
2021 NOSCM | State of the Art Radiation in NSCLC
Lung
Non-CME Credit Course
2021 UCT | Novel Mechanisms of Resistance Identified for Diverse TKIs in NSCLC
Lung
Non-CME Credit Course
Lung Cancer Session
Lung
Non-CME Credit Course
Lung Targeted Therapies in NSCLC - EGFR, ALK, and ROS1
Lung
Non-CME Credit Course
2021 MLS New Orleans | Lung Targeted Therapies in NSCLC: RET, MET and EGFR/HER-2 exon 20
Lung
Non-CME Credit Course
2021 MLS New Orleans | Immunotherapy in Lung
Lung
Non-CME Credit Course
Small cell and Squamous Cell Lung Cancer
Lung
Non-CME Credit Course
2020 Best of WCLC San Francisco | Session IV - Small Cell, Mesothelioma and Thymoma
Lung
Non-CME Credit Course
2020 Best of WCLC San Francisco | Session III - Systemic Treatment for Advanced Stage Non-Small Cell Lung Cancer
Lung
Non-CME Credit Course
2020 Best of WCLC San Francisco | Session II - Locally Advanced Non-Small Cell Lung CancerPathology and Biology
Lung
Non-CME Credit Course
2020 Best of WCLC San Francisco | Session I - Screening Prevention Early-Stage Lung Cancer
Lung
Non-CME Credit Course
2021 CCC | Keynote Lecture – The Future of Targeted Therapy in Lung Cancer
Lung
Non-CME Credit Course
Updates in Immunotherapy for Lung Cancer: Integration of Predictive Biomarkers
Lung
Non-CME Credit Course
2021 CCC | How I treat Stage III NSCLC
Lung
Non-CME Credit Course
2022 WCS | New Developments for Locally Advanced Lung Cancer
Lung
Non-CME Credit Course
Addressing RET, MET, and EGFR/HER-2 Exon 20 insertion
Lung
Non-CME Credit Course
Small cell and Squamous Cell Lung Cancer Update
Lung
Non-CME Credit Course
Contact Us
